Free Trial

Avalo Therapeutics (AVTX) SEC Filings & 10K Form

Avalo Therapeutics logo
$3.75 -0.16 (-4.09%)
Closing price 04:00 PM Eastern
Extended Trading
$3.94 +0.19 (+5.07%)
As of 07:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Avalo Therapeutics SEC Filings

DateFilerForm TypeView
05/15/2025
4:33 PM
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Ikarian Capital, LLC (Filed by)
Form SCHEDULE 13G/A
05/12/2025
6:10 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/12/2025
6:12 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/12/2025
6:01 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2025
6:03 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2025
6:02 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2025
6:00 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form DEF 14A
05/01/2025
6:02 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form DEFA14A
05/01/2025
6:04 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form ARS
04/01/2025
7:06 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Chan Mitchell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
3:37 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
KANTOFF AARON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
3:44 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Truex Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
3:30 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
KAPLAN GILLA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
6:01 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2025
6:02 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2025
6:06 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/30/2025
4:43 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Sullivan Christopher Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
4:51 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
VARKI PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
4:31 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
NEIL GARRY ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
4:20 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Doyle Mittie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
6:07 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
6:04 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2024
3:13 PM
Affinity Asset Advisors, LLC (Filed by)
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Form SCHEDULE 13G
12/05/2024
6:03 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
5:23 PM
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G
11/14/2024
4:21 PM
Almenoff June Sherie (Reporting)
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
11:05 AM
Allostery Investments LP (Filed by)
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Form SC 13G/A
11/12/2024
6:30 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
4:00 PM
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Crutcher Patrick J (Filed by)
Form SC 13G/A
11/07/2024
6:20 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/07/2024
6:02 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:04 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:17 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/08/2024
6:13 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
7:06 PM
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Ikarian Capital, LLC (Filed by)
Form SC 13G
09/09/2024
6:22 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
6:01 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2024
3:34 PM
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Form SC 13G
08/23/2024
3:16 PM
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G
08/14/2024
3:47 PM
Almenoff June Sherie (Reporting)
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
3:36 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
KANTOFF AARON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
July 2025 Rule Change to Impact Retirement Investors (Ad)

There's a massive change from a new rule going into effect this July. And it's one the Big Banks are already using to their advantage… It allows them to treat this new asset like actual cash.

Yes, Send Me My FREE Retirement Guide
08/14/2024
3:27 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Truex Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
6:01 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
6:03 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2024
11:15 PM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form EFFECT
07/16/2024
3:17 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Doyle Mittie (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/16/2024
3:23 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Doyle Mittie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
6:36 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2024
3:24 PM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form S-3/A
07/09/2024
6:17 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
6:04 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form ARS
06/27/2024
6:01 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form DEF 14A
06/27/2024
6:03 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form DEFA14A
06/24/2024
6:14 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
6:01 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form PRE 14A
06/03/2024
6:20 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AVTX) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners